Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by Humaniston Feb 15, 2022 1:06pm
79 Views
Post# 34430621

RE:RE:i wonder what has happened to the FDA APPLICATION

RE:RE:i wonder what has happened to the FDA APPLICATIONI hope youre right Golddetector,  bc i recall reading that they(tbp) siad they're expecting an answer around end of november 21.  but there was no mention since.

thx for the info and your thoughts.
glta


quote=Golddetector]That is still on. Today's deal is part of it. I don't think they can commercialize QIXLEEF as pharmaceutical drug to Latin America but maybe enjocua as medical mj and Reduvo as a drug. Most importantly they need to secure api supplies for the QIXLEEF. Part of fda is inspection to facilitate that deliver the product at certain point of time. There will be more deals according to tetra presentation its part of commercial launch. Obviously they won't do that unless the product is making good progress in trials. I think the meeting is also discussing the packaging and other details. It has been more than 75 days so it might happened already and we will hear soon enough about it.[/quote]

<< Previous
Bullboard Posts
Next >>